Medicine and Dentistry
Macrophage
58%
Peripheral T-Cell Lymphoma
50%
Engraftment
50%
Calreticulin
50%
Regulator Protein
50%
Natural Killer Cell
50%
Retinoic Acid Receptor Alpha
50%
Acute Promyelocytic Leukemia
50%
Pembrolizumab
50%
Esophageal Cancer
50%
Lymphoproliferative Disease
50%
Liver Graft
50%
Diffuse Large B-Cell Lymphoma
50%
Virus
50%
Posttransplant Lymphoproliferative Disease
50%
Engraftment Syndrome
50%
Primary Mediastinal B-Cell Lymphoma
50%
C57BL/6
45%
Xenograft
45%
Stem Cell
44%
Cord Blood
39%
Epstein Barr Virus
37%
Immune Deficiency
37%
Disease
37%
Burkitt's Lymphoma
33%
Hematopoietic Stem Cell
33%
Spontaneous Remission
33%
Donor
33%
Phagocytosis
33%
Cord Blood Stem Cell Transplantation
33%
Hematopoiesis
29%
Acute Myeloid Leukemia
25%
Hematopoietic Stem Cell
25%
Virus Activation
25%
Human Cell
22%
Xenotransplantation
22%
Human Study
22%
Examination
16%
Stem Cell
16%
Cancer Stem Cell
16%
Specimen
16%
NOD Mice
16%
Association
16%
Janus Kinase 2
16%
Biopsy
16%
Lymphocyte
16%
Woman
16%
Transplantation
16%
Patient
16%
Cell Expansion
16%
Immunology and Microbiology
Cytomegalovirus
100%
Cytomegalovirus Infection
90%
Transplantation
67%
Measles Virus
50%
Mouse
50%
Hemophagocytic Lymphohistiocytosis
50%
Stem Cell
50%
Gall Bladder
50%
Autologous Stem Cell Transplantation
50%
Engraftment Syndrome
50%
Incidence
47%
Signaling Lymphocytic Activation Molecule
41%
Cell Transplantation
41%
CD34
35%
Leukemia Cell
35%
Mutation
32%
Host
26%
Syncytium
25%
CD46
25%
Hematopoietic Stem Cell
25%
Bone Marrow
25%
Lineages
25%
Myeloid
21%
Xenograft
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Macrophage
17%
Mortality
16%
Tissues
16%
Clonal Evolution
16%
CD38
14%
Time
13%
Erythropoiesis
12%
Mouse Model
12%
Hematopoiesis
12%
Thrombopoiesis
12%
Virus Resistance
10%
Immune Status
10%
Virus Genome
10%
Drug Resistance
10%
Monospecific Antibody
10%
Gene Mutation
10%
Type Strain
8%
Wild Type
8%
Receptor Binding
8%
Development
8%
Lung Adenocarcinoma Cell Line
8%
Lung Carcinoma Cell Line
8%
Virogenesis
8%
Hemagglutinin
8%
Binding Site
8%
Pharmacology, Toxicology and Pharmaceutical Science
Esophagus Cancer
100%
Lymphoproliferative Disease
50%
Baricitinib
50%
Retinoic Acid Receptor Alpha
50%
Pembrolizumab
50%
Hemophagocytic Syndrome
50%
Promyelocytic Leukemia
50%
Immune Deficiency
37%
Epstein-Barr Virus
37%
Immune Checkpoint Inhibitor
12%
Rituximab
12%
Virus DNA
12%
Fluorouracil
12%
Lung Metastasis
12%
Cisplatin
12%
Cytokine
9%
Acute Myeloid Leukemia
8%
Axicabtagene Ciloleucel
8%
